Prevention of Diabetic Nephropathy in Children and Adolescents: How Effective are the Current Strategies?
Journal Title: International Journal of Diabetology & Vascular Disease Research (IJDVR) - Year 2015, Vol 0, Issue 1
Abstract
This paper aims to review the risk factors for diabetic nephropathy (DN) and the effectiveness of the current strategies for its prevention. Type 1 diabetes mellitus (T1DM) is the predominant form of diabetes in children and adolescents, but the prevalence of Type 2 diabetes mellitus (T2DM) in these age groups is currently increasing worldwide. One of the major challenges of T1DM is the development of DN among other microvascular complications. DN evolves over a long period of time starting from microalbuminuria and progressing to end stage renal failure. While microalbuminuria in children is reversible and may not evolve to end-stage renal failure, macroalbuminuria inevitably progresses to end-stage renal failure irrespective of any known treatment. Several modifiable and non-modifiable risk factors are welldocumented in the literature but addressing a few are critical in the prevention of DN. For instance, tight glycemic control and intensive control of hypertension have significant impact on prevention and progression of DN. From several studies, tight glycemic control has been shown to decrease the risk of microvascular disease in both T1DM and T2DM. Thus, poor glycemic control is critical in the etiology of DN. While tight glycemic control in patients with T1DM reduces the incidence of microalbuminuria and the progression from microalbuminuria to macroalbuminuria, there is overwhelming evidence to show that antihypertensive treatment with angiotensin converting enzyme (ACE) inhibitors is important in both preventing and treating microalbuminuria, and thus preventing progression to overt DN. Dietary protein restriction is also an adjunct strategy in retarding the progression of DN. Other novel therapeutic strategies have been recently tried and found potentially effective. Research is ongoing to establish the clinical efficacy and usefulness of some of these new agents in future.
Authors and Affiliations
SN Uwaezuoke
Keywords
Related Articles
- EP ID EP201883
- DOI 10.19070/2328-353X-SI05001
- Views 87
- Downloads 0
Rhabdomyolysis as an Unusual Complication of Hyperosmolar Hyperglycemic State
Objectives: Hyperosmolar hyperglycemic state (HHS) is one of the serious metabolic derangements that occurs in patients with diabetes mellitus, Cases associated with hyperosmolarity due to diabetic ketoacidosis or hypero...
Clinical Perspective: Diabetes and Calcific Aortic Stenosis
Clinical Perspective: Diabetes and Calcific Aortic Stenosis
Treatment of Hypercholesterolemia in Patients with Diabetes Mellitus
Numerous studies have shown that statins reduce cardiovascular events including stroke and mortality in diabetics. The American Diabetes. Association 2013 guidelines recommend that diabetics at high risk for cardiovascul...
The Diabetic Foot Syndrome an Ignored and Potential Problem in Medical Practice
The Diabetic Foot Syndrome an Ignored and Potential Problem in Medical Practice
Harmonizing Eating and Exercise Circadian Rhythms for Optimal Glucose-Insulin and Vascular Physiology.
This article establishes a global but individual public program based on rhythmic circadian eating and exercise extent and rate to harmonize intermediary metabolism. This will help optimize glucose assimilation and insul...